WO2023053031 - AN IMPROVED PROCESS OF PURIFICATION OF FUSION PROTEIN
National phase entry:
Publication Number
WO/2023/053031
Publication Date
06.04.2023
International Application No.
PCT/IB2022/059239
International Filing Date
28.09.2022
Title **
[English]
AN IMPROVED PROCESS OF PURIFICATION OF FUSION PROTEIN
[French]
PROCÉDÉ AMÉLIORÉ DE PURIFICATION DE PROTÉINE DE FUSION
Applicants **
KASHIV BIOSCIENCES, LLC
20, New England Avenue
Piscataway, New Jersey 08854, US
Inventors
NARAYAN, Om
802, Anvayaa, Makarba Road, Vejalpur, Ahmedabad, Gujarat
Ahmedabad 380051, IN
GALANI, Kishor
D403, Vastupuja Heights, Mota Varachha, Surat, Gujarat
Surat 394101, IN
BHAVSAR, Rupen
17, Gopikrushna Society, Ahmedabad, Gujarat
Ahmedabad 382481, IN
UPADHYAY, Roshan Ganeshlal
NE/36, Shivanand Apartment,
K K Nagar road, Ghatlodia,
Ahmedabad,
Gujarat
Ahmedabad 380061, IN
Priority Data
202121043967
28.09.2021
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1116 | |
| EPO | Filing, Examination | 7067 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2280 |
Total: 11629 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention is directed to the use of anion exchange chromatography to produce a CTLA4-Ig fusion protein with improve glycan.[French]
La présente invention concerne l'utilisation de la chromatographie par échange d'anions pour produire une protéine de fusion CTLA4-Ig avec un glycane amélioré.